Cerebrum 2007: Emerging Ideas in Brain Science
Foreword by Bruce S. McEwen, Ph.D.

Contributors: Margaret Altemus, M.D. • Nicolas G. Bazan, M.D., Ph.D. • Louis R. Caplan, M.D. • Diane C. Chugani, Ph.D. • Jacek Debiec, M.D., Ph.D. • Kathleen M. Foley, M.D. • Henry T. Greely, J.D. • Shelly R. Gunn, M.D., Ph.D. • W. Stewart Gunn • Bruce Hood, Ph.D. • Gale Inoff-Germain • Donald W. Pfaff, Ph.D. • Judith L. Rapoport, M.D. • Kayt Sukel • Maia Szalavitz • Kevin J. Tracey, M.D. • Paul M. Matthews, M.D., D. Phil. • Silvia H. Cardoso, Ph.D. • Lesley J. Rogers, D.Sc., D. Phil. • Gisela Kaplan, Ph.D. • Joseph J. Fins, M.D. • Nicholas D. Schiff, M.D. • David Huron, Ph.D. • Edward McKintosh, MRCS

“Bruce McEwen lays the foundation for this thoughtful integration of ideas from experts in various neuroscientific disciplines addressing real-world problems.... I found this volume to be unusually elegantly written for its genre and worthwhile enough that I went online and asked to be included in the Dana Foundation's distribution list for future such compilations. Given how much professional literature I consume, I suppose that this action is as strong an endorsement as I could make!”

—Review by John E. Ruark, M.D., in PsycCRITIQUES, the book review publication of the American Psychological Association, Vol. 52, Release 44, Article 11

Cerebrum, a one-of-a-kind journal of opinion since 1998, offers inquisitive lay readers insights from prominent neuroscientists and thinkers in fields from philosophy to public policy to the arts. In frequently quoted articles, these authors present, applaud, and protest new ideas arising from discoveries about the brain.

Cerebrum 2007 inaugurates a yearly anthology for readers who like provocative ideas that are transforming every area of our lives. It brings together more than a dozen articles and book reviews from the journal’s Web edition. Readers will be among the first to hear top experts deliver, in concise lay language, what will be tomorrow’s conventional wisdom on topics such as the biological nature of ethical behavior, the brain basis for belief in the supernatural, the science of music, and drugs to alter traumatic memories.             

Cerebrum is published by the Dana Foundation, which has principal interests in science and education. The volume is edited by Cynthia Read, editor of the online journal.

Introduction: Bruce S. McEwen, Ph.D.

Chapter 1: Stroke: We Can and Must Do Better--Improving Stroke Prevention and Treatment Now, Louis R. Caplan, M.D.

Chapter 2: Searching for a New Strategy to Protect the Brain, Nicolas Bazan, M.D., Ph.D.

Chapter 3: Why Not a National Institute on Pain Research?, Kathleen M. Foley, M.D., with Maia Szalavitz

Chapter 4: A Brain Built for Fair Play, Donald W. Pfaff, Ph.D.

Chapter 5: Unshackling the Slaves of Obsession and Compulsion: A Brain Success Story, Judith L. Rapoport, M.D., and Gale Inoff-Germain

Chapter 6: Are We in the Dark About Sleepwalking's Dangers?, Shelly R. Gunn, M.D., and W. Stewart Gunn

Chapter 7: Knowing Sin: Making Sure Good Science Doesn't Go Bad, Henry T. Greely, J.D.

Chapter 8: The Intuitive Magician: Why Belief in the Supernatural Persists, Bruce Hood, Ph.D.

Chapter 9: Bringing the Brain of the Child with Autism Back on Track, Diane Chugani, M.D., and Kayt Sukel

Chapter 10: Toward a New Treatment for Traumatic Memories, Margaret Altemus, M.D., and Jacek Debiec, M.D., Ph.D.

Chapter 11: Elephants That Paint, Birds That Make Music: Do Animals Have an Aesthetic Sense?, Lesley J. Rogers, D.Phil., D.Sc., and Gisela Kaplan, Ph.D.

Chapter 12: Transforming Drug Development Through Brain Imaging, Paul M. Matthews, M.D., D.Phil., FRCP

Chapter 13: Hardwired for Happiness, Silvia Helena Cardoso, Ph.D.

Chapter 14: A Cerebrum Classic: Hope for "Comatose" Patients, Nicholas D. Schiff, M.D., and Joseph J. Fins, M.D.



"Cerebrum is excellent, exciting, and important food for the brain."

-Kay Redfield Jamison, Ph.D., author of Exuberance: The Passion for Life


From Chapter 3

“Why Not a National Institute on Pain Research?” by Kathleen M. Foley, M.D., and Maia Szalavitz

In the past 30 years, we have seen at least some barriers to pain relief—for example, for dying patients—fall dramatically. We are far more aware of the impact of pain on patients and families and of the enormous need for providing approaches that focus on the physical, psychological, social, and spiritual needs of patients and families. Clearly, research on opioid analgesics is not going to be the only solution for all patients with pain. Yet, the role of the opioids today is so central that we need more research to better understand who can benefit from these agents, what risks they impose, and what other drug combinations are effective. Until we have achieved that, though, does it seem reasonable that patients are forced to endure needless suffering because legal or regulatory barriers make existing medications unavailable to them?